Sandra Levy
ARTICLES BY THIS AUTHOR
- 10/3/2021
Zydus Cadila obtains FDA OK for generic Trintellix
Zydus Cadila's generic Trintellix tablets provide a treatment for depression. - 10/3/2021
Sun Pharma intros sunitinib
Sun Pharma's sunitinib capsules are available in four dosage strengths. - 9/30/2021
Merck’s molnupiravir effective in reducing hospitalization, death for patients with moderate COVID-19
If authorized by the Food and Drug Administration, molnupiravir could be the first oral antiviral medicine for COVID-19. - 9/30/2021
Pharmacy pioneer Bruce Kneeland selects 4 road trip pharmacies
The trip, dubbed “Four Savvy Southern Pharmacies,” will include on-site visits and interviews with the owners of pharmacies in Texas, Arkansas, Tennessee and South Carolina. - 9/30/2021
Schnucks to host company-wide career fair
Those hired at the career fair are eligible for the up to $600 performance and retention bonus. - 9/30/2021
Aurobindo receives FDA green light for generic Sabril
Vigabatrin for oral solution has an estimated market size of $262.5 million for the 12 months ended July 2021, according to IQVIA. - 9/29/2021
Amber Specialty Pharmacy, Hy-Vee Pharmacy Solutions to provide Lilly’s COVID-19 antibody treatment
Amber Specialty Pharmacy and Hy-Vee Pharmacy Solutions have 21 locations licensed to administer the antibody treatment and serve patients in all 50 states and Puerto Rico. - 9/29/2021
Kinney Drugs appoints John Marraffa president
Marraffa, a former Walgreens executive, joined KPH Healthcare Services in 2019 as vice president of government affairs and healthcare services integration. - 9/29/2021
Breckenridge receives FDA OK for generic Aubagio
Aubagio had a market value of roughly $1.9 billion during the 12 months ended July 2021, according to industry sales data. - 9/29/2021
FDA gives AbbVie approval for Qulipta
Qulipta is the first and only oral calcitonin gene-related peptide receptor antagonist (gepant) specifically developed for the preventive treatment of migraine.
